|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q40808679
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010711.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q40808679
|
|
024
|
|
|
‡a
0000-0001-8159-2455
‡2
orcid
|
|
024
|
|
|
‡a
14007811300
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q40808679
|
|
100
|
0 |
|
‡a
Irene Latorre
‡9
sl
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Irene Latorre
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Irene Latorre
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Irene Latorre
‡c
investigadora
‡9
es
|
|
400
|
0 |
|
‡a
Irene Latorre
‡c
investigadora
‡9
ast
|
|
670
|
|
|
‡a
Author's A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis
|
|
670
|
|
|
‡a
Author's A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis
|
|
670
|
|
|
‡a
Author's Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.
|
|
670
|
|
|
‡a
Author's Assessment of the influence of direct tobacco smoke on infection and active TB management
|
|
670
|
|
|
‡a
Author's Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study
|
|
670
|
|
|
‡a
Author's Bronchoalveolar lavage immunodiagnosis for tuberculosis suspects in Europe and Africa
|
|
670
|
|
|
‡a
Author's Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients.
|
|
670
|
|
|
‡a
Author's Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy
|
|
670
|
|
|
‡a
Author's Comparison of NxTAG Respiratory Pathogen Panel and Anyplex II RV16 Tests for Multiplex Detection of Respiratory Pathogens in Hospitalized Children.
|
|
670
|
|
|
‡a
Author's Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis.
|
|
670
|
|
|
‡a
Author's Detection of Legionella antigen in nonconcentrated and concentrated urine samples by a new immunochromatographic assay
|
|
670
|
|
|
‡a
Author's Diagnosing TB infection in children: analysis of discordances using in vitro tests and the tuberculin skin test
|
|
670
|
|
|
‡a
Author's Diagnosis and therapeutic approach of latent tuberculosis infection.
|
|
670
|
|
|
‡a
Author's Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis
|
|
670
|
|
|
‡a
Author's Dormancy antigens as biomarkers of latent tuberculosis infection
|
|
670
|
|
|
‡a
Author's Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
|
|
670
|
|
|
‡a
Author's Evaluation of a Legionella urinary antigen enzyme immunoassay for rapid detection of Legionella pneumophila in water samples
|
|
670
|
|
|
‡a
Author's Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers
|
|
670
|
|
|
‡a
Author's Evaluation of the eazyplex MRSA assay for the rapid detection of Staphylococcus aureus in pleural and synovial fluid.
|
|
670
|
|
|
‡a
Author's False-negative interferon-γ release assay results in active tuberculosis: a TBNET study.
|
|
670
|
|
|
‡a
Author's IFN-γ-release assays to diagnose TB infection in the immunocompromised individual
|
|
670
|
|
|
‡a
Author's IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.
|
|
670
|
|
|
‡a
Author's Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice
|
|
670
|
|
|
‡a
Author's Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
|
|
670
|
|
|
‡a
Author's Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment
|
|
670
|
|
|
‡a
Author's IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children
|
|
670
|
|
|
‡a
Author's Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients
|
|
670
|
|
|
‡a
Author's Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing
|
|
670
|
|
|
‡a
Author's Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children
|
|
670
|
|
|
‡a
Author's Rapid detection of pneumococcal antigen in serum samples for diagnosing pneumococcal pneumonia
|
|
670
|
|
|
‡a
Author's Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
|
|
670
|
|
|
‡a
Author's Risk assessment of tuberculosis in immunocompromised patients. A TBNET study
|
|
670
|
|
|
‡a
Author's Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents
|
|
670
|
|
|
‡a
Author's Serial testing of health care workers for tuberculosis infection: A prospective cohort study
|
|
670
|
|
|
‡a
Author's Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy
|
|
670
|
|
|
‡a
Author's T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment
|
|
670
|
|
|
‡a
Author's Técnicas basadas en la detección de IFN-γ en el diagnóstico de la infección tuberculosa en pacientes con psoriasis candidatos a terapias biológicas
|
|
670
|
|
|
‡a
Author's Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study
|
|
670
|
|
|
‡a
Author's Up-to-date applicability of interferon-γ release assays for the diagnosis of tuberculosis
|
|
670
|
|
|
‡a
Author's Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
|
|
670
|
|
|
‡a
Author's Use of interferon-gamma release assays to calculate the annual risk of tuberculosis infection.
|
|
670
|
|
|
‡a
Author's Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia
|
|
670
|
|
|
‡a
Author's Validation of a loop-mediated isothermal amplification assay for rapid diagnosis of pertussis infection in nasopharyngeal samples.
|
|
909
|
|
|
‡a
(orcid) 0000000181592455
‡9
1
|
|
909
|
|
|
‡a
(scopus) 14007811300
‡9
1
|
|
919
|
|
|
‡a
multicentreevaluationoftheaccuracyandperformanceofip10forthediagnosisofinfectionwith1000tuberculosis
‡A
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis
‡9
1
|
|
919
|
|
|
‡a
novelwholebloodmirnasignatureforarapiddiagnosisofpulmonarytuberculosis
‡A
A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis
‡9
1
|
|
919
|
|
|
‡a
accuracyofimmunodiagnostictestsforactivetuberculosisusingsingleandcombinedresultsamulticentertbnetstudy
‡A
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study.
‡9
1
|
|
919
|
|
|
‡a
assessmentoftheinfluenceofdirecttobaccosmokeoninfectionandactivetbmanagement
‡A
Assessment of the influence of direct tobacco smoke on infection and active TB management
‡9
1
|
|
919
|
|
|
‡a
bronchoalveolarlavageenzymelinkedimmunospotforarapiddiagnosisoftuberculosisatuberculosisnetworkeuropeantrialsgroupstudy
‡A
Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study
‡9
1
|
|
919
|
|
|
‡a
bronchoalveolarlavageimmunodiagnosisfortuberculosissuspectsineuropeandafrica
‡A
Bronchoalveolar lavage immunodiagnosis for tuberculosis suspects in Europe and Africa
‡9
1
|
|
919
|
|
|
‡a
calcineurinandmtorinhibitorshaveopposingeffectsonregulatorytcellswhilereducingregulatorybcellpopulationsinkidneytransplantrecipients
‡A
Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients.
‡9
1
|
|
919
|
|
|
‡a
comparisonofamonoclonalwithapolyclonalantibodybasedenzymeimmunoassaystooltestindiagnosinghelicobacterpyloriinfectionbeforeandaftereradicationtherapy
‡A
Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy
‡9
1
|
|
919
|
|
|
‡a
comparisonofnxtagrespiratorypathogenpanelandanyplex2rv16testsformultiplexdetectionofrespiratorypathogensinhospitalizedchildren
‡A
Comparison of NxTAG Respiratory Pathogen Panel and Anyplex II RV16 Tests for Multiplex Detection of Respiratory Pathogens in Hospitalized Children.
‡9
1
|
|
919
|
|
|
‡a
correlationbetweentuberculinskintestandigraswithriskfactorsforthespreadofinfectioninclosecontactswithsputumsmearpositiveinpulmonarytuberculosis
‡A
Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis.
‡9
1
|
|
919
|
|
|
‡a
detectionoflegionellaantigeninnonconcentratedandconcentratedurinesamplesbyanewimmunochromatographicassay
‡A
Detection of Legionella antigen in nonconcentrated and concentrated urine samples by a new immunochromatographic assay
‡9
1
|
|
919
|
|
|
‡a
diagnosingtbinfectioninchildrenanalysisofdiscordancesusinginvitrotestsandthetuberculinskintest
‡A
Diagnosing TB infection in children: analysis of discordances using in vitro tests and the tuberculin skin test
‡9
1
|
|
919
|
|
|
‡a
diagnosisandtherapeuticapproachoflatenttuberculosisinfection
‡A
Diagnosis and therapeutic approach of latent tuberculosis infection.
‡9
1
|
|
919
|
|
|
‡a
diagnosisoftuberculosisinfectionbyinterferongammareleaseassaysinpatientswithpsoriasis
‡A
Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis
‡9
1
|
|
919
|
|
|
‡a
dormancyantigensasbiomarkersoflatenttuberculosisinfection
‡A
Dormancy antigens as biomarkers of latent tuberculosis infection
‡9
1
|
|
919
|
|
|
‡a
evaluatingthenontuberculousmycobacteriaeffectinthetuberculosisinfectiondiagnosis
‡A
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
‡9
1
|
|
919
|
|
|
‡a
evaluationofalegionellaurinaryantigenenzymeimmunoassayforrapiddetectionoflegionellapneumophilainwatersamples
‡A
Evaluation of a Legionella urinary antigen enzyme immunoassay for rapid detection of Legionella pneumophila in water samples
‡9
1
|
|
919
|
|
|
‡a
evaluationofinterferongammareleaseassaysinthediagnosisofrecenttuberculosisinfectioninhealthcareworkers
‡A
Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers
‡9
1
|
|
919
|
|
|
‡a
evaluationoftheeazyplexmrsaassayfortherapiddetectionofstaphylococcusaureusinpleuralandsynovialfluid
‡A
Evaluation of the eazyplex MRSA assay for the rapid detection of Staphylococcus aureus in pleural and synovial fluid.
‡9
1
|
|
919
|
|
|
‡a
falsenegativeinterferonγreleaseassayresultsinactivetuberculosisatbnetstudy
‡A
False-negative interferon-γ release assay results in active tuberculosis: a TBNET study.
‡9
1
|
|
919
|
|
|
‡a
ifnγreleaseassaystodiagnosetbinfectionintheimmunocompromisedindividual
‡A
IFN-γ-release assays to diagnose TB infection in the immunocompromised individual
‡9
1
|
|
919
|
|
|
‡a
ifnγresponseontcellbasedassaysinhivinfectedpatientsfordetectionoftuberculosisinfection
‡A
IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.
‡9
1
|
|
919
|
|
|
‡a
immunemediatedinflammatorydiseasesdifferentlyaffectigrasaccuracyforlatenttuberculosisinfectiondiagnosisinclinicalpractice
‡A
Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice
‡9
1
|
|
919
|
|
|
‡a
immunogenicityof60novellatencyrelatedantigensofmycobacteriumtuberculosis
‡A
Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
‡9
1
|
|
919
|
|
|
‡a
interferongammareleaseassaysinthedetectionoflatenttuberculosisinfectioninpatientswithinflammatoryarthritisscheduledforantitumournecrosisfactortreatment
‡A
Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment
‡9
1
|
|
919
|
|
|
‡a
ip10isanaccuratebiomarkerforthediagnosisoftuberculosisinchildren
‡A
IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children
‡9
1
|
|
919
|
|
|
‡a
performanceoftestsforlatenttuberculosisindifferentgroupsofimmunocompromisedpatients
‡A
Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients
‡9
1
|
|
919
|
|
|
‡a
predictingthedevelopmentoftuberculosiswiththetuberculinskintestandquantiferontesting
‡A
Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing
‡9
1
|
|
919
|
|
|
‡a
quantitativeevaluationoftcellresponseafterspecificantigenstimulationinactiveandlatenttuberculosisinfectioninadultsandchildren
‡A
Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children
‡9
1
|
|
919
|
|
|
‡a
rapiddetectionofpneumococcalantigeninserumsamplesfordiagnosingpneumococcalpneumonia
‡A
Rapid detection of pneumococcal antigen in serum samples for diagnosing pneumococcal pneumonia
‡9
1
|
|
919
|
|
|
‡a
riskassessmentoftuberculosisincontactsbyifnγreleaseassaysatuberculosisnetworkeuropeantrialsgroupstudy
‡A
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
‡9
1
|
|
919
|
|
|
‡a
riskassessmentoftuberculosisinimmunocompromisedpatientsatbnetstudy
‡A
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study
‡9
1
|
|
919
|
|
|
‡a
roleofthetcellinterferongammareleaseassaysinpreventingreactivationoflatenttuberculosisinfectioninimmunosuppressedpatientsintreatmentwithantitnfagents
‡A
Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents
‡9
1
|
|
919
|
|
|
‡a
serialtestingofhealthcareworkersfortuberculosisinfectionaprospectivecohortstudy
‡A
Serial testing of health care workers for tuberculosis infection: A prospective cohort study
‡9
1
|
|
919
|
|
|
‡a
specificmycobacteriumtuberculosistcellresponsestord1selectedpeptidesforthemonitoringofantituberculosistherapy
‡A
Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy
‡9
1
|
|
919
|
|
|
‡a
tcellresponsestothemycobacteriumtuberculosisspecificantigensinactivetuberculosispatientsatthebeginningduringandafterantituberculosistreatment
‡A
T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment
‡9
1
|
|
919
|
|
|
‡a
tecnicasbasadasenladetecciondeifnγeneldiagnosticodelainfecciontuberculosaenpacientesconpsoriasiscandidatosaterapiasbiologicas
‡A
Técnicas basadas en la detección de IFN-γ en el diagnóstico de la infección tuberculosa en pacientes con psoriasis candidatos a terapias biológicas
‡9
1
|
|
919
|
|
|
‡a
thermostabilityofifnγandip10releaseassaysforlatentinfectionwithmycobacteriumtuberculosisatbnetstudy
‡A
Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study
‡9
1
|
|
919
|
|
|
‡a
uptodateapplicabilityofinterferonγreleaseassaysforthediagnosisoftuberculosis
‡A
Up-to-date applicability of interferon-γ release assays for the diagnosis of tuberculosis
‡9
1
|
|
919
|
|
|
‡a
useofifnγandip10detectioninthediagnosisoflatenttuberculosisinfectioninpatientswithinflammatoryrheumaticdiseases
‡A
Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
‡9
1
|
|
919
|
|
|
‡a
useofinterferongammareleaseassaystocalculatetheannualriskoftuberculosisinfection
‡A
Use of interferon-gamma release assays to calculate the annual risk of tuberculosis infection.
‡9
1
|
|
919
|
|
|
‡a
usefulnessofmidregionalproatrialnatriureticpeptideintheexacerbationsofchronicobstructivepulmonarydisease
‡A
Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
usefulnessofpneumococcalantigendetectioninpleuralfluidsamplesbyimmunochromatographicassayfordiagnosisofpneumococcalpneumonia
‡A
Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia
‡9
1
|
|
919
|
|
|
‡a
validationofaloopmediatedisothermalamplificationassayforrapiddiagnosisofpertussisinfectioninnasopharyngealsamples
‡A
Validation of a loop-mediated isothermal amplification assay for rapid diagnosis of pertussis infection in nasopharyngeal samples.
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
LC|n 98009157
|
|
996
|
|
|
‡2
RERO|A003498569
|
|
996
|
|
|
‡2
DNB|1017519498
|
|
996
|
|
|
‡2
ISNI|0000000063017660
|
|
996
|
|
|
‡2
ISNI|0000000356638807
|
|
996
|
|
|
‡2
BNC|981060175545906706
|
|
996
|
|
|
‡2
RERO|A003009094
|
|
996
|
|
|
‡2
J9U|987007402353405171
|
|
996
|
|
|
‡2
DNB|1158863500
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Latorre, Irene
‡2
BNC|981060957918706706
‡3
viafid
‡3
standard number
|
